TW200714284A - Novel method - Google Patents

Novel method

Info

Publication number
TW200714284A
TW200714284A TW095112547A TW95112547A TW200714284A TW 200714284 A TW200714284 A TW 200714284A TW 095112547 A TW095112547 A TW 095112547A TW 95112547 A TW95112547 A TW 95112547A TW 200714284 A TW200714284 A TW 200714284A
Authority
TW
Taiwan
Prior art keywords
novel method
uveitis
vitamin
prevention
compounds
Prior art date
Application number
TW095112547A
Other languages
English (en)
Inventor
Luciano Adorini
Original Assignee
Bioxell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxell Spa filed Critical Bioxell Spa
Publication of TW200714284A publication Critical patent/TW200714284A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095112547A 2005-09-19 2006-04-07 Novel method TW200714284A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71876605P 2005-09-19 2005-09-19

Publications (1)

Publication Number Publication Date
TW200714284A true TW200714284A (en) 2007-04-16

Family

ID=36686035

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095112547A TW200714284A (en) 2005-09-19 2006-04-07 Novel method

Country Status (2)

Country Link
TW (1) TW200714284A (zh)
WO (1) WO2007039322A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE025567T2 (en) * 2011-08-19 2016-02-29 Maria Clementine Martin Klosterfrau Vertriebsges Mbh Agents containing vasoconstrictors for combination therapy
KR102236356B1 (ko) 2017-11-24 2021-04-05 주식회사 종근당 루푸스의 예방 또는 치료를 위한 조성물
KR20190099952A (ko) * 2018-02-20 2019-08-28 주식회사 종근당 포도막염의 예방 또는 치료를 위한 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW422696B (en) * 1995-03-20 2001-02-21 Katsuhiko Mukai Ophthalmic composition containing active vitamin D
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
EP1059085A1 (en) * 1998-02-26 2000-12-13 Chugai Seiyaku Kabushiki Kaisha Langerhans cell migration inhibitors
US20080064668A1 (en) * 2003-09-24 2008-03-13 Bioxell S.P.A. 1,3-Diacylated, 26,27-Alkyl/Haloakyl Vitamin D3 Compounds and Methods of Use Thereof

Also Published As

Publication number Publication date
WO2007039322A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
NL301145I1 (zh)
TW200640924A (en) VEGF-R2 inhibitors and methods
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
EP1951186A4 (en) METHODS FOR TREATING HYPERHIDROSIS
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
SG155163A1 (en) Pharmacokinetically improved compounds
WO2006119329A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP1638950A4 (en) CYCLOHEXYLGLYCIN DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
HK1113085A1 (zh) 治療痘病毒感染的複合物、組分和方法
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
IL176142A0 (en) Processes for preparing montelukast sodium
TNSN08400A1 (en) Organic compounds and their uses
TW200716088A (en) Formulations and methods for treating amyloidosis
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
TW200700071A (en) Novel use
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
TW200806297A (en) Methods for treating cognitive and other disorders
TW200510398A (en) Novel compounds
TW200638932A (en) CCI-779 polymorph and use thereof
HK1115528A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof